Viewing Study NCT01502202

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 4:04 AM
Ignite Modification Date: 2026-02-25 @ 8:59 PM
Study NCT ID: NCT01502202
Status: UNKNOWN
Last Update Posted: 2012-06-20
First Post: 2011-12-22
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Intercalated Administration of PamCis With Gefitinib or Placebo as First Line Lung Adenocarcinoma in Never Smokers
Sponsor: National Cancer Center, Korea
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Non Small Cell Lung Cancer View
None Adenocarcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None lung adenocarcinoma View
None never smoker View
None 1st line treatment View
None Intercalation administration View
None Gefitinib View
None never smokers View